Skip to Content



Growth is central to Almirall's long-term strategy. Besides our own organic expansion, we also partner with selected companies in the industry. We believe that our partnerships enable us to offer a balanced, competitive portfolio of products, while expanding the global reach of our business, to bring innovative solutions to patients around the world.

Our partnerships cover the whole of the medicine value chain, led by Almirall's geographic and therapeutic priorities. Our experience in partnering with other companies reaches from the first stages of development to the registration and subsequent commercialisation.

Almirall seeks both in-licensing opportunities and strategic partners to out-license its own R&D products.